LEP and breast carcinoma: Leptin’s role in ASC-mediated tumor progression was demonstrated by the use of leptin silencing shRNA in obese ASCs, which prevented the enhanced proliferative effects of obese ASC on breast cancer cells following co-culture of ASCs with breast cancer cells [139].